MVA ME-TRAP/ChAd63 ME-TRAP
/ University of Oxford
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
December 06, 2024
Comparing Safety and Protective Efficacy of Vaccine Candidate PfSPZ-CVac and MVA ME-TRAP/ ChAd63 ME-TRAP in Adults
(clinicaltrials.gov)
- P1/2 | N=30 | Not yet recruiting | Sponsor: University Hospital Tuebingen | Trial completion date: Oct 2025 ➔ Jun 2026 | Trial primary completion date: Oct 2025 ➔ Jun 2026
Trial completion date • Trial primary completion date • Viral vector • Infectious Disease • Malaria
May 08, 2024
Comparing Safety and Protective Efficacy of Vaccine Candidate PfSPZ-CVac and MVA ME-TRAP/ ChAd63 ME-TRAP in Adults
(clinicaltrials.gov)
- P1/2 | N=30 | Not yet recruiting | Sponsor: University Hospital Tuebingen | Trial completion date: Apr 2024 ➔ Oct 2025 | Trial primary completion date: Apr 2024 ➔ Oct 2025
Trial completion date • Trial primary completion date • Viral vector • Infectious Disease • Malaria
June 02, 2023
Comparing Safety and Protective Efficacy of Vaccine Candidate PfSPZ-CVac and MVA ME-TRAP/ ChAd63 ME-TRAP in Adults
(clinicaltrials.gov)
- P1/2 | N=30 | Not yet recruiting | Sponsor: University Hospital Tuebingen | Trial completion date: Apr 2023 ➔ Apr 2024 | Initiation date: Oct 2022 ➔ Oct 2023 | Trial primary completion date: Apr 2023 ➔ Apr 2024
Trial completion date • Trial initiation date • Trial primary completion date • Viral vector • Infectious Disease • Malaria
July 01, 2022
Comparing Safety and Protective Efficacy of Vaccine Candidate PfSPZ-CVac and MVA ME-TRAP/ ChAd63 ME-TRAP in Adults
(clinicaltrials.gov)
- P1/2 | N=30 | Not yet recruiting | Sponsor: University Hospital Tuebingen
New P1/2 trial • Infectious Disease • Malaria
1 to 4
Of
4
Go to page
1